Skip to main content
ANTEROGEN CO., LTD. logo

ANTEROGEN CO., LTD. — Investor Relations & Filings

Ticker · 065660 ISIN · KR7065660003 KO Manufacturing
Open in API
Filings indexed 267 across all filing types
Latest filing 2025-12-24 Major Shareholding Noti…
Country KR South Korea
Listing KO 065660

About ANTEROGEN CO., LTD.

http://anterogen.com

ANTEROGEN CO., LTD. is a bio-venture company engaged in the research, development, and commercialization of cell therapy products and orphan drugs. The company specializes in utilizing adult stem cells, particularly adipose-derived mesenchymal stem cells, to create innovative treatments. Its key commercialized products include Cupistem®, an autologous stem cell therapy for Crohn's fistula, and Queencell®. Anterogen's research pipeline extends to applications for musculoskeletal diseases, spinal injuries, and cardiovascular conditions. The company also offers stem cell banking services.

Recent filings

Filing Released Lang Actions
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea for reporting significant changes in share ownership (often referred to as a 5% report). It details the reporter (Lee Sung-koo), special related parties, and changes in their shareholding percentages in Antrogen Co., Ltd. This falls under the category of Major Shareholding Notification.
2025-12-24 Korean
[기재정정]반기보고서 (2021.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for the company '안트로젠' (Anterogen). It contains detailed financial information, business descriptions, management discussions, and shareholding structures for the period ending June 30, 2021. Although it is labeled as a '정정신고' (Correction Report), it is a comprehensive financial report for an interim period, which falls under the 'Interim / Quarterly Report' category. H1 2021
2025-12-22 Korean
[기재정정]분기보고서 (2021.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'Anterogen' (주식회사 안트로젠), covering the period from January 1, 2021, to September 30, 2021. It contains detailed financial information, business descriptions, and management disclosures typical of a quarterly filing. Although it includes a 'correction' (정정) notice at the beginning, the document itself is a comprehensive interim report, not merely an announcement of one. 9M 2021
2025-12-22 Korean
[기재정정]사업보고서 (2021.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the company 'Anterogen' (주식회사 안트로젠). It contains detailed financial information, business operations, shareholding structures, and management details for the fiscal year 2021. Although it is labeled as a 'correction' (정정신고), it constitutes the full annual report filing required by regulatory bodies (Financial Services Commission/Korea Exchange). It is not a mere announcement of a report, but the report itself, containing substantive financial and operational data. FY 2021
2025-12-22 Korean
[기재정정]분기보고서 (2022.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '안트로젠' (Anterogen). It contains detailed financial information, business operations, management discussions, and shareholding structures for the period ending March 31, 2022. Although it includes a '정정신고' (Correction Report) header, the core content is a comprehensive quarterly financial report, which falls under the 'Interim / Quarterly Report' category. Q1 2022
2025-12-22 Korean
[기재정정]반기보고서 (2022.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Half-Year Report) for the company '안트로젠' (Anterogen). It contains detailed financial information, business descriptions, and management discussions for the period of 2022-01-01 to 2022-06-30. Although it is labeled as a '정정신고' (Correction Report), the core content is the interim financial report itself, which fits the definition of an Interim/Quarterly Report (IR). H1 2022
2025-12-22 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.